Skip to main content

Table 1 Characteristics of evaluated policies (n) across the spillover pathway1

From: Policies to prevent zoonotic spillover: a systematic scoping review of evaluative evidence

Characteristics

Total (n (%))

 

Spillover pathway stage

Wildlife distribution and density

Pathogen prevalence

Pathogen survival and spread

Domesticate animal exposure

Within-domesticated animal barriers

Domesticated animal distribution and density

Pathogen prevalence

Pathogen survival and spread

Human exposure

Within-human barriers

Multiple stages

Target population

 

Wildlife

Domesticated animals

Humans

Multiple

Total (n (%))

111 (100)

5 (5)

7 (6)

1(1)

4 (4)

17 (15)

1 (1)

18 (16)

10 (9)

23 (21)

5 (5)

20 (18)

Policy and governance level

            

Local

34 (31)

1

3

0

2

4

1

0

4

15

0

4

National

54 (49)

2

3

1

4

8

0

14

3

5

5

11

Regional (e.g., European region)

9 (8)

0

0

0

0

2

0

3

1

1

0

2

Global

6 (7)

1

0

0

0

1

0

0

1

0

0

3

Policy and governance sector

            

Animal health

18 (16)

0

0

0

3

3

0

6

1

1

0

4

Environment

5 (5)

1

1

1

0

0

0

1

1

0

0

0

Human health

17 (15)

0

0

0

0

2

0

0

1

9

4

1

Multi-sectoral

26 (23)

2

2

0

0

3

0

4

2

6

1

6

Other or not stated

45 (41)

2

4

0

1

9

1

7

5

7

0

9

Implementing sector

            

Retail

19 (17)

0

0

0

0

0

1

0

5

13

0

0

Trade

7 (6)

0

1

0

0

0

0

2

1

3

0

0

Farming

47 (42)

2

0

1

4

13

0

10

4

3

0

10

Human health

8 (7)

0

0

0

0

1

0

0

0

0

5

2

Animal health

8 (7)

0

0

0

0

3

0

2

0

1

0

2

Conservation

9 (8)

3

6

0

0

0

0

0

0

0

0

0

Other or multiple

13 (12)

0

0

0

0

0

0

4

0

3

0

6

Country income

            

High

52 (47)

2

7

0

3

5

0

11

5

7

3

9

Upper middle

31 (28)

2

0

1

1

4

1

3

4

14

0

1

Lower middle

23 (21)

1

0

0

0

7

0

4

1

1

2

7

Low

2 (2)

0

0

0

0

0

0

0

0

1

0

1

Region

            

East Asia and Pacific

46 (41)

1

1

0

2

4

1

8

7

18

2

2

Europe and Central Asia

21 (19)

1

1

0

2

4

0

4

2

2

1

4

Latin America & the Caribbean

4 (4)

1

0

0

0

3

0

0

0

0

0

0

Middle East and North Africa

4 (4)

0

0

0

0

2

0

1

0

0

0

1

North America

17 (15)

1

5

0

0

1

0

1

1

2

2

4

South Asia

2 (2)

1

0

0

0

0

0

0

0

0

0

1

Sub-Saharan Africa

14 (13)

0

0

1

0

2

0

4

0

1

0

6

Global

1 (1)

0

0

0

0

1

0

0

0

0

0

0

Disease

            

Avian influenza

55 (50)

1

0

0

2

5

1

6

9

18

12

12

Brucellosis

12 (11)

1

0

0

0

3

0

4

0

3

1

1

Hendra virus

4 (4)

0

0

0

2

1

0

0

0

1

0

0

Rabies

21 (19)

2

6

0

0

6

0

2

0

0

2

2

Other

19 (17)

1

1

1

0

2

0

6

1

1

5

5

Evaluation type

            

Formative

18 (16)

1

3

0

0

3

0

6

0

0

0

5

Process

42 (38)

0

0

0

4

4

0

9

4

9

3

9

Outcome

35 (32)

2

2

1

0

5

1

3

6

14

0

1

Economic

13 (12)

1

2

0

0

3

0

0

0

0

2

5

Impact

3 (3)

1

0

0

0

2

0

0

0

0

0

0

Policy instrument

            

Communication/marketing

6 (5)

0

0

0

1

0

0

0

1

4

0

0

Regulation

4 (4)

0

0

1

0

1

0

0

0

2

0

0

Legislation

65 (59)

3

1

0

2

14

1

16

8

16

0

0

Service provision

16 (14)

2

6

0

0

1

0

1

0

0

5

1

Multiple instruments

20 (18)

0

0

0

1

1

0

1

1

1

0

15

  1. 1Infection intensity and pathogen release in both wildlife and domesticated animals are excluded from the table as no relevant studies were identified; policy numbers do not add up to 111 for all characteristics (country income, region and governance level), reflecting modelling studies where this contextual information was not provided as framing for the study